Role of Extracellular Vesicles in Bone-Muscle Crosstalk with Aging

细胞外囊泡在衰老过程中骨-肌肉串扰中的作用

基本信息

项目摘要

ABSTRACT Osteoporosis and sarcopenia are diseases of aging that frequently occur together and reduce quality of life in the elderly population. Evidence is emerging for signaling crosstalk between bone and muscle via circulating and local mediators, leading to the concept that muscle-bone crosstalk may coordinate age- related degenerative changes. An exciting new paradigm in cell-cell communication is that extracellular vesicles (EV) (exosomes and microvesicles) may provide a novel mechanism for communication between cells. It has also been proposed that circulating muscle-derived exosomes (termed “exersomes”) may mediate some of the beneficial effects of exercise in the body. EV are membrane-bound particles shed from cells with a cargo of proteins, mRNAs and microRNAs (miRNAs). The EV dock with a target cell, delivering their cargo and altering its function. We have shown that young and aged osteocytes shed EV, which may provide a novel mechanism for regulation of osteoblast function. Live cell imaging suggests osteocytes shed EV from their cell body and dendrites and may shed them into the circulation. Osteocyte EV are taken up by osteoblasts and myoblasts and have potent effects on osteoblasts to promote differentiation towards an early osteocyte phenotype. EV from myoblasts and myotubes are taken up by osteocytes and induce β-catenin signaling. These findings lead to our overall hypothesis that extracellular vesicles (EV) are important regulators of bone and muscle cell function and provide a novel mechanism for crosstalk between muscle and bone that may regulate age-related osteoporosis and sarcopenia. This hypothesis will be tested using complimentary in vitro and in vivo approaches and using intravital imaging in young and aged mouse models with fluorescent reporters to tag bone and muscle cells. Aim 1 will determine the role of EV in regulating osteocyte-osteoblast reciprocal interactions in vitro and in vivo and how this is altered by aging and exercise. This will be done using EV from osteoblast and osteocyte cell lines and primary cells to determine EV effects on the differentiated function of the reciprocal cell type. Aim 2 will determine the role of EV in regulating muscle-bone crosstalk and how it is altered by aging and exercise. This will be done using EV from myoblast, osteoblast and osteocyte cell lines and primary cells to determine EV effects on the differentiated function of the reciprocal cell types. In both aims, live cell and intravital imaging will determine the kinetics of EV release and uptake in muscle and bone cells in vitro and in vivo. Young and aged mouse models will be used with and without wheel running exercise to determine in vitro and in vivo the effect of aging and exercise on EV release, composition and function. These studies may result in paradigm shifting insight into the mechanisms of molecular crosstalk between bone and muscle and will pave the way for exploiting the potential of muscle and bone derived EVs as circulating biomarkers and as novel therapeutics for age related bone and muscle loss.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SARAH L DALLAS其他文献

SARAH L DALLAS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SARAH L DALLAS', 18)}}的其他基金

Leica Stellaris 8 Confocal Microscope System
Leica Stellaris 8 共焦显微镜系统
  • 批准号:
    10431037
  • 财政年份:
    2022
  • 资助金额:
    $ 33.53万
  • 项目类别:
Role of Extracellular Vesicles in Bone-Muscle Crosstalk with Aging
细胞外囊泡在衰老过程中骨-肌肉串扰中的作用
  • 批准号:
    10166745
  • 财政年份:
    2012
  • 资助金额:
    $ 33.53万
  • 项目类别:
Muscle-Bone Imaging Core
肌肉骨骼成像核心
  • 批准号:
    10413015
  • 财政年份:
    2012
  • 资助金额:
    $ 33.53万
  • 项目类别:
Muscle-Bone Imaging Core
肌肉骨骼成像核心
  • 批准号:
    10166741
  • 财政年份:
    2012
  • 资助金额:
    $ 33.53万
  • 项目类别:
Osteocyte Control of Osteoblast Dynamics with Aging
骨细胞对衰老过程中成骨细胞动力学的控制
  • 批准号:
    8281074
  • 财政年份:
    2012
  • 资助金额:
    $ 33.53万
  • 项目类别:
Optimizing Normal Collagen Replacement in Osteogenesis Imperfecta
优化成骨不全患者的正常胶原蛋白替代
  • 批准号:
    8502630
  • 财政年份:
    2012
  • 资助金额:
    $ 33.53万
  • 项目类别:
Optimizing Normal Collagen Replacement in Osteogenesis Imperfecta
优化成骨不全患者的正常胶原蛋白替代
  • 批准号:
    8390315
  • 财政年份:
    2012
  • 资助金额:
    $ 33.53万
  • 项目类别:
Muscle/Bone Phenotyping Core
肌肉/骨骼表型核心
  • 批准号:
    8281057
  • 财政年份:
    2012
  • 资助金额:
    $ 33.53万
  • 项目类别:
Zeiss LSM 710 Confocal Microscopy System for Imaging of Mineralized Tissues
用于矿化组织成像的蔡司 LSM 710 共焦显微镜系统
  • 批准号:
    8050238
  • 财政年份:
    2011
  • 资助金额:
    $ 33.53万
  • 项目类别:
Dynamics of Assembly of Bone Matrix Proteins
骨基质蛋白组装动力学
  • 批准号:
    7871226
  • 财政年份:
    2009
  • 资助金额:
    $ 33.53万
  • 项目类别:

相似海外基金

Optimizing Small Molecule Mechanomimetics to Treat Age-related Osteoporosis.
优化小分子力学模拟治疗与年龄相关的骨质疏松症。
  • 批准号:
    10807685
  • 财政年份:
    2023
  • 资助金额:
    $ 33.53万
  • 项目类别:
Pathophysiology of age-related osteoporosis by cellular senescence
细胞衰老导致的年龄相关性骨质疏松症的病理生理学
  • 批准号:
    23K15689
  • 财政年份:
    2023
  • 资助金额:
    $ 33.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
PKG Regulation of Sirtuin 1 as a Novel Treatment Strategy for Age-related Osteoporosis
Sirtuin 1 的 PKG 调节作为年龄相关性骨质疏松症的新型治疗策略
  • 批准号:
    10634657
  • 财政年份:
    2021
  • 资助金额:
    $ 33.53万
  • 项目类别:
PKG Regulation of Sirtuin 1 as a Novel Treatment Strategy for Age-related Osteoporosis
Sirtuin 1 的 PKG 调节作为年龄相关性骨质疏松症的新型治疗策略
  • 批准号:
    10296605
  • 财政年份:
    2021
  • 资助金额:
    $ 33.53万
  • 项目类别:
PKG Regulation of Sirtuin 1 as a Novel Treatment Strategy for Age-related Osteoporosis
Sirtuin 1 的 PKG 调节作为年龄相关性骨质疏松症的新型治疗策略
  • 批准号:
    10478942
  • 财政年份:
    2021
  • 资助金额:
    $ 33.53万
  • 项目类别:
The development and analyses of the mouse model of age-related osteoporosis.
年龄相关性骨质疏松症小鼠模型的建立和分析。
  • 批准号:
    21791416
  • 财政年份:
    2009
  • 资助金额:
    $ 33.53万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
CHANGES OF PARATHYROIDS AND BONE TISSUES IN AGE-RELATED OSTEOPOROSIS: WITH SPECIAL REGERENCES TO PTHrP and AGEs.
年龄相关性骨质疏松症中甲状旁腺和骨组织的变化:特别关注 PTHrP 和 AGE。
  • 批准号:
    12670187
  • 财政年份:
    2000
  • 资助金额:
    $ 33.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
GLUOCORTICOIDS, OSTEOCYTES, AND BONE STENGTH IN AGE-RELATED OSTEOPOROSIS
年龄相关性骨质疏松症中的糖皮质激素、骨细胞和骨强度
  • 批准号:
    7628477
  • 财政年份:
  • 资助金额:
    $ 33.53万
  • 项目类别:
GLUOCORTICOIDS, OSTEOCYTES, AND BONE STENGTH IN AGE-RELATED OSTEOPOROSIS
年龄相关性骨质疏松症中的糖皮质激素、骨细胞和骨强度
  • 批准号:
    7560562
  • 财政年份:
  • 资助金额:
    $ 33.53万
  • 项目类别:
GLUOCORTICOIDS, OSTEOCYTES, AND BONE STENGTH IN AGE-RELATED OSTEOPOROSIS
年龄相关性骨质疏松症中的糖皮质激素、骨细胞和骨强度
  • 批准号:
    7869378
  • 财政年份:
  • 资助金额:
    $ 33.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了